Delivery Order SPE2DR25D1202-SPE2DR26F71MN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Sacubitril-Valsartan 24-26 mg in 60-count quantities, with a contract ceiling value of $10,688.40. This firm fixed price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,166.08 for Sacubitril-Valsartan 97-103 mg tablets (60-count) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count) valued at $2,202.57. This is a firm fixed-price, non-set-aside contract with performance to be completed by September 16, 2025, and fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,703.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 5, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's ongoing pharmaceutical supply operations...
- The Defense Logistics Agency awarded a delivery order valued at $18,186.68 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60 count) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $4,589.05 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (180-count). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,868.48 delivery order to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,741.44 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg in quantities of 60 tablets. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $44,508.93 delivery order to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 49-51 mg tablets (180-count supply) under a firm fixed price contract structure. The award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71MNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Sacubitril-Valsartan 97-103 mg in 60-count quantities, valued at $3,128.66 with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement supporting federal healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 10/20/25 |